Pilot Observational Study and Safety Analysis of FL Nourish Capsules in Cancer Patients in Remission

Inclusion Criteria: * Aged 21-80; * Cancer diagnosis ≤ 5 years; * Received treatment with no current evidence of recurrence, with predicted life expectancy of 12 months and above; * On regular follow-up with lab tests scheduled every 1-9 months; * Recent (\<=3 months) blood test report(s) available on first study visit * Diagnosed with the TCM syndrome of Qi deficiency and Blood stasis by the primary physician: experience 2 major symptoms coupled with typical tongue and pulse conditions; 2 major symptoms and 1 possible symptom coupled with tongue and pulse conditions; and 1 major symptom and at least 2 possible symptoms coupled with tongue and pulse conditions; Exclusion Criteria: * On active cancer treatment such as IV chemotherapy or radiotherapy or oral targeted therapy (excluding HRT and oral chemotherapy); * Scheduled for IV chemotherapy, radiotherapy or surgery within the next 1 year from recruitment date; * Diagnosed with active disease of the liver, kidney, brain, blood, blood vessels; with mental health conditions or are mentally incapacitated; * Pregnant women.